Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.
The item "Other-Long-Term-Liabilities" stands at 635.29 Billion Japanese Yens as of 09/30/2025.
As of the end of Takeda Pharmaceutical Co. Ltd.'s second quarter, the item "Other Long Term Liabilities" stands at 635.29 Billion JPY. This represents an increase of 1.76 percent compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -0.6286 percent compared to the value the year prior.
The 1 year change in percent is -0.6286.
The 3 year change in percent is 2.69.
The 5 year change in percent is 21.16.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Other Long Term Liabilities | 905,699,262,464.00 |
![]() | Johnson & Johnson - Other Long Term Liabilities | 486,508,953,600.00 |
![]() | AbbVie Inc - Other Long Term Liabilities | 399,570,305,024.00 |
![]() | Roche Holding AG - Other Long Term Liabilities | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Other Long Term Liabilities | 280,205,508,085.11 |